Global COPD and Asthma Devices Market
Degrading air quality near the industrial areas has led to the increased incidence of asthma especially in the low-income population in the emerging economies of China, India, Brazil and Russia. Increasing disposable income levels in emerging economies as well as developing countries of Latin America, Middle East & Africa has led to the increased usage of asthma pumps and sprays in these regions.
Global COPD and Asthma Devices Market Overview
The global asthma and COPD drug market is a multi-billion dollar market which has a history of several decades and has witnessed number of technological advancements and product development over the past few years. Growing aging population coupled with increasing automotive and industrial exhaust gases have remained the key drivers for the global asthma and COPD market. Degrading air quality near the industrial areas has led to the increased incidence of asthma especially in the low-income population in the emerging economies of China, India, Brazil and Russia. Increasing disposable income levels in emerging economies as well as developing countries of Latin America, Middle East & Africa has led to the increased usage of asthma pumps and sprays in these regions. However, the unknown etiology of asthma and COPD in medical industry may hamper the market growth in the next six years. Upcoming treatment methodologies such as once-a-day combination products and monoclonal antibodies have created new opportunities for the market growth. Additionally, pharmaceutical companies have been developing new bio-based medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for asthma & COPD market over the next decade.
Global COPD and Asthma Devices Market Highlights
The report highlights the adoption of COPD & Asthma Devices worldwide. Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market. The geographies included in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).
Global COPD and Asthma Devices Market Key Companies
Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.
Global COPD and Asthma Devices Market Segmentation
Global Commercial Telematics Market
- Global COPD & Asthma Devices, By Product Type
- Global COPD & Asthma Devices Market
- Global COPD & Asthma Inhaler Market
- Global COPD & Asthma Dry Powder Inhalers (DPIs) Market
- Global COPD & Asthma Metered Dose Inhalers (MDIs) Market
- Global COPD & Asthma Soft Mist Inhalers (SMIs) Market
- Global COPD & Asthma Nebulizer Market
- Global COPD & Asthma Pneumatic Nebulizers Market
- Global COPD & Asthma Ultrasonic Nebulizer Market
- Global COPD & Asthma Mesh Nebulizer Market
- Global COPD & Asthma Inhaler Market
Global COPD & Asthma Devices Market, By Country
- North America
- S
- Mexico
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Global COPD & Asthma Devices Market
Unique Offerings from KBV Research
- Exhaustive coverage of Global COPD and Asthma Devices Market
- Highest number of market tables (1079 Tables, 573 Pages)
- Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
- Subscription based model available
- Free of cost quarterly updates
- Free of cost automatic pdf report generation
- Guaranteed best price
- Assured post sales research support with 10% customization free
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 MARKET SCOPE
1.4 SEGMENTATION
1.4.1 Global COPD & Asthma Devices, By Product Type
1.4.2 Global COPD & Asthma Devices Market, By Country
1.5 Research Methodology
Chapter 2. GLOBAL COPD AND ASTHMA DEVICES MARKET OVERVIEW
2.1 Introduction
2.2 Key Influencing Factors
2.3 North America COPD & Asthma Device Market
2.4 Europe COPD & Asthma Device Market
2.5 Asia Pacific COPD & Asthma Device Market
2.6 LAMEA COPD & Asthma Device Market
Chapter 3. Global COPD and Asthma Device Market – By Product Type
3.1 Global COPD & Asthma Inhaler Market
3.1.1 Global COPD & Asthma Inhaler Market – By Product Type
3.1.1.1 Global COPD & Asthma Dry Powder Inhalers (DPIs) Market – By Geography
3.1.1.1.1 North America COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.2 Europe COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.3 Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.4 LAMEA COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.2 Global COPD & Asthma Metered Dose Inhalers (MDIs) Market – By Geography
3.1.1.2.1 North America COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.2 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.3 Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.4 LAMEA COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.3 Global COPD & Asthma Soft Mist Inhalers (SMIs) Market – By Geography
3.1.1.3.1 North America COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.3.2 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.3.3 Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.3.4 LAMEA COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.2 Global COPD & Asthma Inhaler Market – By Geography
3.1.2.1 North America COPD & Asthma Inhaler Market
3.1.2.1.1 North America COPD & Asthma Inhaler Market – By Country
3.1.2.1.2 North America COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.1.3 North America COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.1.4 North America COPD & Asthma Soft Mist Inhalers (MDIs) Market
3.1.2.2 Europe COPD & Asthma Inhaler Market
3.1.2.2.1 Europe COPD & Asthma Inhaler Market – By Country
3.1.2.2.2 Europe COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.2.3 Europe COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.2.4 Europe COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.2.3 Asia Pacific COPD & Asthma Inhaler Market
3.1.2.3.1 Asia Pacific COPD & Asthma Inhaler Market – By Country
3.1.2.3.2 Asia Pacific COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.3.3 Asia Pacific COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.3.4 Asia Pacific COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.2.4 LAMEA COPD & Asthma Inhaler Market
3.1.2.4.1 LAMEA COPD & Asthma Inhaler Market – By Country
3.1.2.4.2 LAMEA COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.2.4.3 LAMEA COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.2.4.4 LAMEA COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.2 Global COPD & Asthma Nebulizer Market
3.2.1 Global COPD & Asthma Nebulizer Market – By Type
3.2.1.1 Global COPD & Asthma Pneumatic Nebulizers Market- By Geography
3.2.1.1.1 North America COPD & Asthma Pneumatic Nebulizers Market
3.2.1.1.2 Europe COPD & Asthma Pneumatic Nebulizer Market
3.2.1.1.3 Asia Pacific COPD & Asthma Pneumatic Nebulizer Market
3.2.1.1.4 LAMEA COPD & Asthma Pneumatic Nebulizer Market
3.2.1.2 Global COPD & Asthma Ultrasonic Nebulizer Market – By Geography
3.2.1.2.1 North America COPD & Asthma Ultrasonic Nebulizer Market – By Country
3.2.1.2.2 Europe COPD & Asthma Ultrasonic Nebulizer Market – By Country
3.2.1.2.3 Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market – By Country
3.2.1.2.4 LAMEA COPD & Asthma Ultrasonic Nebulizer Market – By Country
3.2.1.3 Global COPD & Asthma Mesh Nebulizer Market – By Geography
3.2.1.3.1 North America COPD & Asthma Mesh Nebulizer Market- By Country
3.2.1.3.2 Europe COPD & Asthma Mesh Nebulizer Market – By Country
3.2.1.3.3 Asia Pacific COPD & Asthma Mesh Nebulizer Market – By Country
3.2.1.3.4 LAMEA COPD & Asthma Mesh Nebulizer Market – By Country
3.2.2 Global COPD & Asthma Nebulizer Market – By Geography
3.2.2.1 North America COPD & Asthma Nebulizer Market – By Type
3.2.2.2 North America COPD & Asthma Nebulizer Market – By Country
3.2.2.3 North America COPD & Asthma Pneumatic Nebulizer Market
3.2.2.4 North America COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.5 North America COPD & Asthma Mesh Nebulizer Market
3.2.2.6 Europe COPD & Asthma Nebulizer Market – By Product Type
3.2.2.6.1 Europe COPD & Asthma Nebulizer Market – By Country
3.2.2.6.2 Europe COPD & Asthma Pneumatic Nebulizer Market
3.2.2.6.3 Europe COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.6.4 Europe COPD & Asthma Mesh Nebulizer Market
3.2.2.7 Asia Pacific COPD & Asthma Nebulizer Market – By Product Type
3.2.2.7.1 Asia Pacific COPD & Asthma Nebulizer Market – By Country
3.2.2.7.2 Asia Pacific COPD & Asthma Pneumatic Nebulizer Market
3.2.2.7.3 Asia Pacific COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.7.4 Asia Pacific COPD & Asthma Mesh Nebulizer Market
3.2.2.8 LAMEA COPD & Asthma Nebulizer Market – By Product Type
3.2.2.8.1 LAMEA COPD & Asthma Nebulizer Market – By Country
3.2.2.8.2 LAMEA COPD & Asthma Pneumatic Nebulizer Market
3.2.2.8.3 LAMEA COPD & Asthma Ultrasonic Nebulizer Market
3.2.2.8.4 LAMEA COPD & Asthma Mesh Nebulizer Market
Chapter 4. Global COPD & Asthma Devices Market – By Geography
4.1 North America COPD & Asthma Device Market
4.1.1 U.S COPD and Asthma Devices Market
4.1.1.1 U.S COPD and Asthma Devices Market – By Product Type
4.1.1.1.1 U.S COPD and Asthma Inhalers Market
4.1.1.1.2 U.S COPD and Asthma Nebulizers Market
4.1.2 Canada COPD and Asthma Devices Market
4.1.2.1 Canada COPD and Asthma Devices Market – By Product Type
4.1.2.1.1 Canada COPD and Asthma Inhalers Market – By Product Type
4.1.2.1.2 Canada COPD and Asthma Nebulizers Market
4.1.3 Mexico COPD and Asthma Devices Market
4.1.3.1 Mexico COPD and Asthma Devices Market – By Product Type
4.1.3.1.1 Mexico COPD and Asthma Inhalers Market
4.1.3.1.2 Mexico COPD and Asthma Nebulizers Market – By Product Type
4.1.4 Rest of North America COPD and Asthma Devices Market
4.1.4.1 Rest of North America COPD and Asthma Devices Market – By Product Type
4.1.4.1.1 Rest of North America COPD and Asthma Inhalers Market
4.1.4.1.2 Rest of North America COPD and Asthma Nebulizers Market
4.2 Europe COPD & Asthma Device Market
4.2.1 Russia COPD and Asthma Devices Market
4.2.1.1 Russia COPD and Asthma Devices Market – By Product Type
4.2.1.1.1 Russia COPD and Asthma Inhalers Market – By Product Type
4.2.1.1.2 Russia COPD and Asthma Nebulizers Market
4.2.2 Germany COPD and Asthma Devices Market
4.2.2.1 Germany COPD and Asthma Devices Market – By Product Type
4.2.2.1.1 Germany COPD and Asthma Inhalers Market
4.2.2.1.2 Germany COPD and Asthma Nebulizers Market
4.2.3 UK COPD and Asthma Devices Market
4.2.3.1 UK COPD and Asthma Devices Market
4.2.3.1.1 UK COPD and Asthma Inhalers Market
4.2.3.1.2 UK COPD and Asthma Nebulizers Market
4.2.4 France COPD and Asthma Devices Market
4.2.4.1 France COPD and Asthma Devices Market – By Product Type
4.2.4.1.1 France COPD and Asthma Inhalers Market
4.2.4.1.2 France COPD and Asthma Nebulizers Market
4.2.5 Spain COPD and Asthma Devices Market
4.2.5.1 Spain COPD and Asthma Devices Market – By Product Type
4.2.5.1.1 Spain COPD and Asthma Inhalers Market
4.2.5.1.2 Spain COPD and Asthma Nebulizers Market
4.2.6 Italy COPD and Asthma Devices Market
4.2.6.1 Italy COPD and Asthma Devices Market – By Product Type
4.2.6.1.1 Italy COPD and Asthma Inhalers Market
4.2.6.1.2 Italy COPD and Asthma Nebulizers Market
4.2.7 Rest of Europe COPD and Asthma Devices Market
4.2.7.1 Rest of Europe COPD and Asthma Devices Market – By Product Type
4.2.7.1.1 Rest of Europe COPD and Asthma Inhalers Market
4.2.7.1.2 Rest of Europe COPD and Asthma Nebulizers Market
4.3 Asia Pacific COPD & Asthma Device Market
4.3.1 China COPD and Asthma Devices Market
4.3.1.1 China COPD and Asthma Devices Market – By Product Type
4.3.1.1.1 China COPD and Asthma Inhalers Market
4.3.1.1.2 China COPD and Asthma Nebulizers Market
4.3.2 Japan COPD and Asthma Devices Market
4.3.2.1 Japan COPD and Asthma Devices Market – By Product Type
4.3.2.1.1 Japan COPD and Asthma Inhalers Market
4.3.2.1.2 Japan COPD and Asthma Nebulizers Market
4.3.3 India COPD and Asthma Devices Market
4.3.3.1 India COPD and Asthma Inhalers Market – By Product Type
4.3.3.1.1 India COPD and Asthma Inhalers Market
4.3.3.1.2 India COPD and Asthma Nebulizers Market
4.3.4 South Korea COPD and Asthma Devices Market
4.3.4.1 South Korea COPD and Asthma Devices Market – By Product Type
4.3.4.1.1 South Korea COPD and Asthma Inhalers Market
4.3.4.1.2 South Korea COPD and Asthma Nebulizers Market
4.3.5 Australia COPD and Asthma Devices Market
4.3.5.1 Australia COPD and Asthma Devices Market – By Product Type
4.3.5.1.1 Australia COPD and Asthma Inhalers Market
4.3.5.1.2 Australia COPD and Asthma Nebulizers Market
4.3.6 Malaysia COPD and Asthma Devices Market
4.3.6.1 Malaysia COPD and Asthma Devices Market – By Product Type
4.3.6.1.1 Malaysia COPD and Asthma Inhalers Market
4.3.6.1.2 Malaysia COPD and Asthma Nebulizers Market
4.3.7 Rest of Asia Pacific COPD and Asthma Devices Market
4.3.7.1 Rest of Asia Pacific COPD and Asthma Devices Market – By Product Type
4.3.7.1.1 Rest of Asia Pacific COPD and Asthma Inhalers Market
4.3.7.1.2 Rest of Asia Pacific COPD and Asthma Nebulizers Market
4.4 LAMEA COPD & Asthma Device Market
4.4.1 Brazil COPD and Asthma Devices Market
4.4.1.1 Brazil COPD and Asthma Devices Market – By Product Type
4.4.1.1.1 Brazil COPD and Asthma Inhalers Market
4.4.1.1.2 Brazil COPD and Asthma Nebulizers Market
4.4.2 Argentina COPD and Asthma Devices Market
4.4.2.1 Argentina COPD and Asthma Devices Market – By Product Type
4.4.2.1.1 Argentina COPD and Asthma Inhalers Market
4.4.2.1.2 Argentina COPD and Asthma Nebulizers Market
4.4.3 UAE COPD and Asthma Devices Market
4.4.3.1 UAE COPD and Asthma Devices Market – By Product Type
4.4.3.1.1 UAE COPD and Asthma Inhalers Market
4.4.3.1.2 UAE COPD and Asthma Nebulizers Market
4.4.4 Saudi Arabia COPD and Asthma Devices Market
4.4.4.1 Saudi Arabia COPD and Asthma Devices Market – By Product Type
4.4.4.1.1 Saudi Arabia COPD and Asthma Inhalers Market
4.4.4.1.2 Saudi Arabia COPD and Asthma Nebulizers Market
4.4.5 South Africa COPD and Asthma Devices Market
4.4.5.1 South Africa COPD and Asthma Devices Market – By Product Type
4.4.5.1.1 South Africa COPD and Asthma Inhalers Market
4.4.5.1.2 South Africa COPD and Asthma Nebulizers Market
4.4.6 Nigeria COPD and Asthma Devices Market
4.4.6.1 Nigeria COPD and Asthma Devices Market – By Product Type
4.4.6.1.1 Nigeria COPD and Asthma Inhalers Market
4.4.6.1.2 Nigeria COPD and Asthma Nebulizers Market
4.4.7 Rest of LAMEA COPD and Asthma Devices Market
4.4.7.1 Rest of LAMEA COPD and Asthma Devices Market – By Product Type
4.4.7.1.1 Rest of LAMEA COPD and Asthma Inhalers Market
4.4.7.1.2 Rest of LAMEA COPD and Asthma Nebulizers Market
Chapter 5. Company Profiles
5.1 Glaxosmithcline PLC
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental Analysis
5.1.4 Research & Development
5.2 Novartis International AG
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental Analysis
5.2.4 Research & Development
5.3 Merck & Co., Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental Analysis
5.3.4 Research & Development
5.4 AstraZeneca Plc
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental Analysis
5.4.4 Research & Development
5.5 3M Healthcare
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental Analysis
5.5.4 Research & Development
5.6 GF Health Products, Inc
5.6.1 Company Overview
5.7 Sunovion Pharmaceuticals Inc.
5.7.1 Company Overview
5.8 Smith Medicals, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.9 Baxter International
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental Analysis
5.9.4 Research & Development
5.1 Koninklijke Philips N.V.
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental Analysis
5.10.4 Research & Development
List of Tables
TABLE 1 GLOBAL COPD AND ASTHMA DEVICES MARKET ($ MILLION): 2012-2015
TABLE 2 GLOBAL COPD AND ASTHMA DEVICES MARKET ($ MILLION): 2016-2022
TABLE 3 GLOBAL COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 4 GLOBAL COPD AND ASTHMA DEVICES MARKET ($ MILLION): 2016-2022
TABLE 5 NORTH AMERICA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 6 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET ($ MILLION): 2016-2022
TABLE 7 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 8 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 9 EUROPE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 10 NORTH AMERICA COPD AND ASTHMA DEVICES MARKET ($ MILLION): 2016-2022
TABLE 11 EUROPE COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 12 EUROPE COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 13 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 14 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 15 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 16 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 17 LAMEA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 18 LAMEA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 19 LAMEA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 20 LAMEA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 21 GLOBAL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 22 GLOBAL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 23 GLOBAL COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 24 GLOBAL COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 25 GLOBAL COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 26 GLOBAL COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 27 NORTH AMERICA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 28 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 29 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 30 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 31 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 32 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 33 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 34 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 35 GLOBAL COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 36 GLOBAL COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 37 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 38 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 39 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2012-2015
TABLE 40 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2016-2022
TABLE 41 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 42 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 43 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 44 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 45 GLOBAL COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2012-2015
TABLE 46 GLOBAL COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2016-2022
TABLE 47 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 48 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 49 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2012-2015
TABLE 50 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2016-2022
TABLE 51 ASIA PACIFIC COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 52 ASIA PACIFIC COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 53 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 54 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 55 GLOBAL COPD AND ASTHMA INHALER MARKET ($ MILLION): 2012-2015
TABLE 56 GLOBAL COPD AND ASTHMA INHALER MARKET ($ MILLION): 2016-2022
TABLE 57 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 58 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 59 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 60 NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 61 NORTH AMERICA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 62 NORTH AMERICA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 63 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 64 NORTH AMERICA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 65 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 66 NORTH AMERICA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 67 EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 68 EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 69 EUROPE COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 70 EUROPE COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 71 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 72 EUROPE COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 73 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2012-2015
TABLE 74 EUROPE COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET ($ MILLION): 2016-2022
TABLE 75 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2012-2015
TABLE 76 EUROPE COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET ($ MILLION): 2016-2022
TABLE 77 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 78 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 79 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 80 ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 81 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 82 ASIA PACIFIC COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 83 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 84 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 85 ASIA PACIFIC COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 86 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 87 LAMEA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 88 LAMEA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 89 LAMEA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 90 LAMEA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 91 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 92 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 93 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 94 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 95 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 96 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 97 GLOBAL COPD AND ASTHMA NEBULIZER MARKET – BY TYPE ($ MILLION): 2012-2015
TABLE 98 GLOBAL COPD AND ASTHMA NEBULIZER MARKET – BY TYPE ($ MILLION): 2016-2022
TABLE 99 GLOBAL COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 100 GLOBAL COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 101 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 102 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 103 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 104 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 105 ASIA PACIFIC COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 106 ASIA PACIFIC COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 107 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 108 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 109 GLOBAL COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 110 GLOBAL COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 111 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 112 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 113 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 114 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 115 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 116 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 117 LAMEA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 118 LAMEA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 119 GLOBAL COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 120 GLOBAL COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 121 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 122 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 123 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 124 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 125 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 126 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 127 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 128 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 129 GLOBAL COPD AND ASTHMA NEBULIZERS MARKET ($ MILLION): 2012-2015
TABLE 130 GLOBAL COPD AND ASTHMA NEBULIZERS MARKET ($ MILLION): 2016-2022
TABLE 131 NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 132 NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 133 NORTH AMERICA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 134 NORTH AMERICA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 135 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 136 NORTH AMERICA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-202
TABLE 137 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 138 NORTH AMERICA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 139 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2012-2015
TABLE 140 NORTH AMERICA COPD AND ASTHMA MESH NEBULIZER MARKET- BY COUNTRY ($ MILLION): 2016-2022
TABLE 141 EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 142 EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 143 113
TABLE 144 EUROPE COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 145 EUROPE COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 146 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 147 EUROPE COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 148 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 149 EUROPE COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 150 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 151 EUROPE COPD AND ASTHMA MESH NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 152 ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 153 ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 154 ASIA PACIFIC COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 155 ASIA PACIFIC COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 156 ASIA PACIFIC COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 157 ASIA PACIFIC COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 158 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 159 ASIA PACIFIC COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 160 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 161 ASIA PACIFIC COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 162 LAMEA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 163 LAMEA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 164 LAMEA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 165 LAMEA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 166 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 167 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 168 LAMEA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 169 LAMEA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 170 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 171 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 172 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 173 NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 174 U.S COPD & ASTHMA DEVICE MARKET: 2012-2015
TABLE 175 U.S COPD & ASTHMA DEVICE MARKET: (2016-2022)
TABLE 176 U.S COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 177 U.S COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 178 U.S COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 179 U.S COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE(2016-2022)
TABLE 180 U.S COPD AND ASTHMA NEBULIZER MARKET (2016-2022)
TABLE 181 CANADA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2012-2015)
TABLE 182 CANADA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2016-2022)
TABLE 183 CANADA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 184 CANADA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 185 CANADA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 186 CANADA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 187 CANADA COPD AND ASTHMA NEBULIZER MARKET (2012-2015)
TABLE 188 CANADA COPD AND ASTHMA NEBULIZER MARKET (2016-2022)
TABLE 189 MEXICO COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2012-2016)
TABLE 190 MEXICO COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2016-2022)
TABLE 191 MEXICO COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 192 MEXICO COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 193 MEXICO COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 194 MEXICO COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 195 MEXICO COPD AND ASTHMA NEBULIZER MARKET (2012-2016)
TABLE 196 MEXICO COPD AND ASTHMA NEBULIZER MARKET (2016-2022)
TABLE 197 REST OF NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2012-2015)
TABLE 198 REST OF NORTH AMERICA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY (2016-2022)
TABLE 199 REST OF NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 200 REST OF NORTH AMERICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 201 REST OF NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2012-2015)
TABLE 202 REST OF NORTH AMERICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE (2016-2022)
TABLE 203 REST OF NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET (2012-2015)
TABLE 204 REST OF NORTH AMERICA COPD AND ASTHMA NEBULIZER MARKET (2016-2022)
TABLE 205 EUROPE COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 206 EUROPE COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 207 RUSSIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 208 RUSSIA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 209 RUSSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 210 RUSSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 211 RUSSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 212 RUSSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 213 RUSSIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 214 RUSSIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 215 GERMANY COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 216 GERMANY COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 217 GERMANY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 218 GERMANY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 219 GERMANY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 220 GERMANY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 221 GERMANY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 222 GERMANY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 223 UK COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 224 UK COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 225 UK COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 226 UK COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 227 UK COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 228 UK COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 229 UK COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 230 UK COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 231 FRANCE COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 232 FRANCE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 233 NCE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 234 FRANCE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 235 FRANCE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 236 FRANCE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 237 FRANCE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 238 FRANCE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 239 SPAIN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 240 SPAIN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 241 SPAIN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 242 SPAIN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 243 SPAIN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 244 SPAIN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 245 SPAIN COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 246 SPAIN COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 247 ITALY COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 248 ITALY COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 249 ITALY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 250 ITALY COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 251 ITALY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 252 ITALY COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 253 ITALY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 254 ITALY COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 255 REST OF EUROPE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 256 REST OF EUROPE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 257 REST OF EUROPE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 258 REST OF EUROPE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 259 REST OF EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 260 REST OF EUROPE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 261 REST OF EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 262 REST OF EUROPE COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 263 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 264 ASIA PACIFIC COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 265 CHINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 266 CHINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 267 CHINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 268 CHINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 269 CHINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 270 CHINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 271 CHINA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 272 CHINA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 273 JAPAN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 274 JAPAN COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 275 JAPAN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 276 JAPAN COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 277 JAPAN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 278 JAPAN COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 279 JAPAN COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 280 JAPAN COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 281 INDIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 282 INDIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 283 INDIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 284 INDIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 285 INDIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 286 INDIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 287 INDIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 288 INDIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 289 SOUTH KOREA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 290 SOUTH KOREA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 291 SOUTH KOREA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 292 SOUTH KOREA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 293 SOUTH KOREA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 294 SOUTH KOREA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 295 SOUTH KOREA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 296 SOUTH KOREA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 297 AUSTRALIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 298 AUSTRALIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 299 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 300 AUSTRALIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 301 AUSTRALIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 302 AUSTRALIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 303 AUSTRALIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 304 AUSTRALIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 305 MALAYSIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 306 MALAYSIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 307 MALAYSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 308 MALAYSIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 309 MALAYSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 310 MALAYSIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 311 MALAYSIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 312 MALAYSIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 313 REST OF ASIA PACIFIC COPD & ASTHMA DEVICE MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 314 REST OF ASIA PACIFIC COPD & ASTHMA DEVICE MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 315 REST OF ASIA PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 316 REST OF ASIA PACIFIC COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 317 REST OF ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 318 REST OF ASIA PACIFIC COPD AND ASTHMA INHALERS MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 319 REST OF ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 320 REST OF ASIA PACIFIC COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 321 LAMEA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 322 LAMEA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 323 BRAZIL COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 324 BRAZIL COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 325 BRAZIL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 326 BRAZIL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 327 BRAZIL COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 328 BRAZIL COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 329 BRAZIL COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 330 BRAZIL COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 331 ARGENTINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 332 ARGENTINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 333 ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 334 ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 335 ARGENTINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 336 ARGENTINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 337 ARGENTINA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 338 ARGENTINA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 339 UAE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 340 UAE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 341 UAE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 342 UAE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 343 UAE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 344 UAE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 345 UAE COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 346 UAE COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 347 SAUDI ARABIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 348 SAUDI ARABIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 349 SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 350 SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 351 SAUDI ARABIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 352 SAUDI ARABIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 353 SAUDI ARABIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 354 SAUDI ARABIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 355 SOUTH AFRICA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 356 SOUTH AFRICA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 357 SOUTH AFRICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 358 SOUTH AFRICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 359 SOUTH AFRICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 360 SOUTH AFRICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 361 SOUTH AFRICA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 362 SOUTH AFRICA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 363 NIGERIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 364 NIGERIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 365 NIGERIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 366 NIGERIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 367 NIGERIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 368 NIGERIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 369 NIGERIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 370 NIGERIA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 371 REST OF LAMEA COPD & ASTHMA DEVICE MARKET – BY COUNTRY ($ MILLION): 2012-2015
TABLE 372 REST OF LAMEA COPD & ASTHMA DEVICE MARKET – BY COUNTRY ($ MILLION): 2016-2022
TABLE 373 REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 374 REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 375 REST OF LAMEA COPD AND ASTHMA INHALERS MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 376 REST OF LAMEA COPD AND ASTHMA INHALERS MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 377 REST OF LAMEA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 378 REST OF LAMEA COPD AND ASTHMA NEBULIZER MARKET – BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 1 KEY INFORMATION – GLAXOSMITHCLINE PLC.
TABLE 2 KEY INFORMATION – NOVARTIS INTERNATIONAL AG.
TABLE 3 KEY INFORMATION – BIOTRONIK SE & CO. KG.
TABLE 4 KEY INFORMATION – ASTRAZENECA PLC.
TABLE 5 KEY INFORMATION – 3M HEALTHCARE.
TABLE 6 KEY INFORMATION – GF HEALTH PRODUCTS, INC.
TABLE 7 KEY INFORMATION – SUNOVION PHARMACEUTICALS INC.
TABLE 8 KEY INFORMATION – SMITH MEDICALS, INC.
TABLE 9 KEY INFORMATION – BAXTER INTERNATIONAL.
TABLE 10 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
